The University of Iowa link

Publications

2011-2013   |   2010   |   2009   |   2008   |   2007   |   1999-2006

1999-2006

Publications

Coffey CS and Muller KE. Exact Test Size and Power of a Gaussian Error Linear Model for an Internal Pilot Study, Statistics in Medicine, 18:1199-1214, 1999. (PMC Journal - In Process)

Coffey CS and Muller KE. Properties of Doubly-Truncated Gamma Variables, Communications in Statistics-Theory and Methods, 29(4):851-857, 2000.

Coffey CS and Muller KE. Some Distributions and Their Implications for an Internal Pilot Study With a Univariate Linear Model, Communications in Statistics-Theory and Methods, 29(12):2677-2691, 2000.

Coffey CS and Muller KE. Controlling Test Size While Gaining the Benefits of an Internal Pilot Design, Biometrics, 57:625-631, 2001. (PMC Journal - In Process)

Perz JF, Craig AS, Coffey CS, Jorgensen DM, Mitchel E, Hall S, Schaffner W, and Griffin MR. Changes in Antibiotic Prescribing for Children After a Community-Wide Campaign, Journal of the American Medical Association, 287(23):3103-3109, 2002. (PMC Journal - In Process)

Ko DT, Hebert PR, Coffey CS, Sedrakyan A, Curtis JP, and Krumholz HM. Beta Blocker Therapy and Symptoms of Depression, Fatigue, and Sexual Dysfunction, Journal of the American Medical Association, 288(3):351-357, 2002. (PMC Journal - In Process)

Coffey CS and Muller KE. Properties of Internal Pilots with the Univariate Approach to Repeated Measures, Statistics in Medicine, 22:2469-2485, 2003. (PMC Journal - In Process)

Gadbury GL, Coffey CS, and Allison DB. Modern Statistical Methods for Handling Missing Repeated Measurements in Obesity Trial Data: Beyond LOCF, Obesity Reviews, 4:175-184, 2003. (PMC Journal - In Process)

Ko DT, Hebert PR, Coffey CS, Curtis JP, Foody JM, Sedrakyan A, and Krumholz HM. Adverse Effects of Beta Blocker Therapy for Heart Failure Patients: A Quantitative Overview of Randomized Trials, Archives of Internal Medicine, 164(13):1389-1394, 2004. (PMC Journal - In Process)

Coffey CS, Steiner D, Baker BA, and Allison DB. A Randomized Double-Blind Placebo Controlled Clinical Trial of a Product Containing Ephedrine, Caffeine, and Other Ingredients from Herbal Sources for Treatment of Overweight and Obesity in the Absence of Lifestyle Treatment, International Journal of Obesity, 28(11):1411-1419, 2004. (PMC Journal - In Process)

Coffey CS, Gadbury GL, Fontaine KR, Wang C, Weindruch R, and Allison DB. The Effects of Intentional Weight Loss as a Latent Variable Problem, Statistics in Medicine, 24(6):941-954, 2005. (PMC Journal - In Process)

Howard GH, Coffey CS, and Cutter GR. Is Bayesian Analysis Ready for Use in Phase III Randomized Clinical Trials "Beware the Sound of the Sirens", Stroke, 36:1622-1623, 2005. (PMC Journal - In Process)

Del Brutto OH, Roos KL, Coffey CS, and Garcia HH. Albendazole and Praziquantel Therapy for Neurocysticercosis: A Meta-Analysis of Randomized Trials, Annals of Internal Medicine, 145:43-51, 2006. (PMC Journal - In Process)

Adams HP Jr, Woolson RF, Biller J, Clarke W, and the TOAST Study Group. Studies of Org 10172 in patients with acute ischemic stroke. Haemostasis 22:99-

Thal LJ, Carta A, Clarke WR, Ferris SH, Friedland RP, Petersen RC, Pettegrew JW, Pfeiffer E, Raskind MA, Sano M, Tuszynski MH, Woolson RF. A 1-year multicenter placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer's disease. Neurology 47:705-711, 1996.

Adams HP Jr., Woolson RF, Clarke WR, Davis PH, Bendixen BH, Love BB, Wasek P, and Grimsman K. Design of the trial of org 10172 in acute stroke treatment (TOAST). Controlled Clinical Trials 18:358-377, 1997.

The TOAST Study Group. Results of a Randomized, placebo-controlled trial of the low molecular weight Heparinoid, ORG 10172, in improving outcome after acute ischemic stroke. JAMA, 279:1265-1272, 1998.

Adams HP, Bendixen BH, Leira E, Chang KC, Davis PH, Woolson RF, Clarke WR, Hansen MD. Antithrombotic treatment of ischemic stroke among patients with occlusion or severe stenosis of the internal carotid artery: A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology 53(1):122-125, 1999.

Rodby RA, Rohde RD, Clarke WR, Hunsicker LG, Anzalone DA, Atkins RC, Ritz E, Lewis EJ. The Irbesartan type II diabetic nephropathy trial: study design and baseline patient characteristics. For the Collaborative Study Group. Nephrol Dial Transplant Apr; 15(4):487-97, 2000.

Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, Ritz E, Atkins RC, Rohde R, Raz I. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. NEJM 345(12):851-60, 2001.

Adams HPJr, Powers WJ, Grubb RL Jr, Clarke WR, Woolson RF. Preview of a new trial of extracranial-to-intracranial arterial anastomosis: the carotid occlusion surgery study. Neurosurg Clin N Am Jul;12(3):613-624, ix-x, 2001.

Grubb RL Jr, Powers WJ, Derdeyn CP, Adams HP, Clarke WR. The carotid occlusion surgery study. Neurosurg Focus 14(3):Article 9, 2003.

Adams HP, Leclerc JR, Bluhmki E, Clarke W, Hansen MD, Hacke W. Measuring outcomes as a function of baseline severity of ischemic stroke. Cerebrovasc Dis 18(2):124-129, 2004.

Leira EC, Chang KC, Davis PH, Clarke WR, Woolson RF, Hansen MD, Adams HP. Can we predict early recurrence in acute stroke? Cerebrovasc Dis 18(2):139-144, 2004.

Todd, MM, Hindman BJ, Clarke, WR, Torner JC, for the Intraoperative Hypothermia for Aneurysm Surgery Trial (IHAST) Investigators. Mild intraoperative hypothermia during surgery for intracranial aneurysm. N Eng J Med 352:135-45, 2005.

Wang W, Woolson RF, Clarke WR. Estimating and Testing Treatment Effects on Two Binary Endpoints and Association Between Endpoints in Clinical Trials. Communications in Statistics-Simulation and Computation 34:751-69, 2005.

Anderson, SW, Todd MM, Hindman BJ, Clarke WR, Torner JC, Tranel D., Yoo B, Weeks J, Manzel KW, Samra S. Effects of Intraoperative Hypothermia on Neuropsychological Outcomes after Intracranial Aneurysm Surgery. Ann Neurol Nov. 21; 60(5):518-527, 2006.

Short Courses and Workshops

Coffey, CS, Mehta C. Faculty Member, 'Adaptive Designs and Clinical Trials' pre-conference workshop sponsored by the Society for Clinical Trials, May 2005, (Portland, OR)

Coffey, CS. Faculty Member, 'Frequentist Adaptive Designs, Internal Pilots, and Stopping Rules' lecture as part of a Conference on Design, Analysis, and Interpretation of Randomized Clinical Trials in Obesity, December 2006, (Newark, NJ)